» Articles » PMID: 36059517

Antioxidant Effect of Grape Seed Extract Corrects Experimental Autoimmune Encephalomyelitis Behavioral Dysfunctions, Demyelination, and Glial Activation

Overview
Journal Front Immunol
Date 2022 Sep 5
PMID 36059517
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Multiple sclerosis (MS), a multifactorial autoimmune disease of the central nervous system (CNS), is characterized by demyelination and chronic inflammation, as well as axonal and neuronal loss. There is no cure for MS, and despite a significant improvement in the therapeutic management of patients during the last 20 years, some symptoms are still resistant to treatment, and the evolution of the disease to progressive form seems still ineluctable. The etiology of MS is complex and still not fully understood. However, inflammation is a major driver of physiopathology and oxidative stress contributes to CNS lesions and promotes existing inflammatory response. Plant polyphenols are endowed with many therapeutic benefits through alleviating oxidative stress and inflammation, thus providing neuroprotection in MS. We presently evaluated the curative effect of grape seed extract (GSE) in an experimental autoimmune encephalomyelitis (EAE) mouse model of MS.

Experimental Approach: Six-week-old C57Bl/6J females were subjected to the EAE paradigm (using myelin oligodendrocyte glycoprotein peptide fragment (35-55), complete Freund's adjuvant, and pertussis toxin) and then chronically treated with GSE from day 10 to day 30 post-induction. Clinical score and body weight were monitored daily, while evaluation of sensitive, motor, cognitive, and anxiety-related behaviors was performed weekly. Then, the GSE effect was evaluated on whole brain and spinal cord samples through the evaluation of oxidative stress damage, antioxidant capacities, myelin alteration, astroglial and microglial proliferation, and sirtuin expression.

Key Results: Grape seed extract curative chronic treatment corrected the clinical course of EAE, as well as the mechanical hypersensitivity, and avoided the development of EAE mouse thermal cold allodynia. The neuropathological evaluation showed that GSE reduced oxidative stress in the brain and spinal cord by decreasing the lipid and protein oxidation through correction of the three main antioxidant enzyme activities, namely, superoxide dismutase, catalase, and glutathione peroxidase, as well as restoring normal myelin protein expression and correcting microglial and astroglial protein overexpression and sirtuin downregulation.

Conclusion And Implications: These data strongly support GSE as an effective therapeutic approach in MS treatment.

Citing Articles

Obesity Control and Supplementary Nutraceuticals as Cofactors of Brain Plasticity in Multiple Sclerosis Populations.

Ciumarnean L, Sarb O, Draghici N, Salagean O, Milaciu M, Orasan O Int J Mol Sci. 2024; 25(20).

PMID: 39456690 PMC: 11507128. DOI: 10.3390/ijms252010909.


Antioxidant Therapies in the Treatment of Multiple Sclerosis.

Jimenez-Jimenez F, Alonso-Navarro H, Salgado-Camara P, Garcia-Martin E, Agundez J Biomolecules. 2024; 14(10).

PMID: 39456199 PMC: 11506420. DOI: 10.3390/biom14101266.


Hepatic Transcriptome Reveals Potential Key Genes Contributing to Differential Milk Production.

Du C, Zhu La A, Gao S, Gao W, Ma L, Bu D Genes (Basel). 2024; 15(9).

PMID: 39336820 PMC: 11431119. DOI: 10.3390/genes15091229.


Predictive Model of Anxiety and Depression Perception in Multiple Sclerosis Patients: Possible Implications for Clinical Treatment.

Cuerda-Ballester M, Bustos A, Sancho-Cantus D, Martinez-Rubio D, Privado J, Alarcon-Jimenez J Bioengineering (Basel). 2024; 11(1).

PMID: 38275580 PMC: 10813122. DOI: 10.3390/bioengineering11010100.


Understanding the spectrum of non-motor symptoms in multiple sclerosis: insights from animal models.

Weerasinghe-Mudiyanselage P, Kim J, Shin T, Moon C Neural Regen Res. 2023; 19(1):84-91.

PMID: 37488849 PMC: 10479859. DOI: 10.4103/1673-5374.375307.

References
1.
Luo F, Tran A, Xin L, Sanapala C, Lang B, Silver J . Modulation of proteoglycan receptor PTPσ enhances MMP-2 activity to promote recovery from multiple sclerosis. Nat Commun. 2018; 9(1):4126. PMC: 6175851. DOI: 10.1038/s41467-018-06505-6. View

2.
Chaplan S, Bach F, Pogrel J, Chung J, Yaksh T . Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994; 53(1):55-63. DOI: 10.1016/0165-0270(94)90144-9. View

3.
Zimmermann M . Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983; 16(2):109-110. DOI: 10.1016/0304-3959(83)90201-4. View

4.
Marck C, De Livera A, Weiland T, Jelinek P, Neate S, Brown C . Pain in People with Multiple Sclerosis: Associations with Modifiable Lifestyle Factors, Fatigue, Depression, Anxiety, and Mental Health Quality of Life. Front Neurol. 2017; 8:461. PMC: 5591834. DOI: 10.3389/fneur.2017.00461. View

5.
Peruga I, Hartwig S, Thone J, Hovemann B, Gold R, Juckel G . Inflammation modulates anxiety in an animal model of multiple sclerosis. Behav Brain Res. 2011; 220(1):20-9. DOI: 10.1016/j.bbr.2011.01.018. View